Lyndsey E Collins-Praino

Prof. Lyndsey E Collins-Praino

The University of Adelaide, Adelaide, South Australia
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SSShannon Stuckey
Shannon Stuckey
Lin Kooi OngLin Kooi Ong
Lin Kooi Ong
LCLyndsey E Collins-Praino
Lyndsey E Collins-Praino
Renee Jade TurnerRenee Jade Turner
Renee Jade Turner
Ischaemic stroke involves the rapid onset of focal neurological dysfunction, most commonly due to an arterial blockage in a specific region of the brain. Stroke is a leading cause of death and common cause of disability, with over 17 million people worldwide suffering from a stroke each year. It is now well-documented that neuroinflammation and immune mediators play a key role in acute and long-term neuronal tissue damage and healing, not only in the infarct core but also in distal regions. Importantly, in these distal regions, termed sites of secondary neurodegeneration (SND), spikes in neuroinflammation may be seen sometime after the initial stroke onset, but prior to the presence of the neuronal tissue damage within these regions. However, it is key to acknowledge that, despite the mounting information describing neuroinflammation following ischaemic stroke, the exact mechanisms whereby inflammatory cells and their mediators drive stroke-induced neuroinflammation are still not fully understood. As a result, current anti-inflammatory treatments have failed to show efficacy in clinical trials. In this review we discuss the complexities of post-stroke neuroinflammation, specifically how it affects neuronal tissue and post-stroke outcome acutely, chronically, and in sites of SND. We then discuss current and previously assessed anti-inflammatory therapies, with a particular focus on how failed anti-inflammatories may be repurposed to target SND-associated neuroinflammation.

1 August 2019 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
DSDimitrios Saredakis
Dimitrios Saredakis
LCLyndsey E Collins-Praino
Lyndsey E Collins-Praino
DGDaria S. Gutteridge
Daria S. Gutteridge
BSBlossom Stephan
Blossom Stephan
HKHannah Keage
Hannah Keage

1 April 2010 in Neuroscience
Verified
Journal Article
Closed access
AFA.M. Farrar
A.M. Farrar
KSK.N. Segovia
K.N. Segovia
PRP.A. Randall
P.A. Randall
ENE.J. Nunes
E.J. Nunes
LCLyndsey E Collins-Praino
Lyndsey E Collins-Praino
JSJ.D. Salamone
J.D. Salamone

9 January 2009 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
AMAllison M. Mott
Allison M. Mott
ENEric J. Nunes
Eric J. Nunes
LCLyndsey E Collins-Praino
Lyndsey E Collins-Praino
RPRussell G. Port
Russell G. Port
KSKelly S. Sink
Kelly S. Sink
JSJohn D. Salamone
John D. Salamone

3 March 2009 in Behavioural Brain Research
Verified
Journal Article
Closed access
JSJohn D. Salamone
John D. Salamone
AFAndrew M. Farrar
Andrew M. Farrar
LFLaura Font
Laura Font
VPVatsal Patel
Vatsal Patel
DSDevra E. Schlar
Devra E. Schlar
TSThomas N. Sager
Thomas N. Sager